Mkts

Iovance Biotherapeutics, Inc.

NASDAQ: IOVA
$8.59+0.55 (+6.84%)
As of Nov 9, 12:40 PM ET

Key statistics

Day range
7.818.91
52-week range
2.0815.37
Today
Open8.01
Previous close8.59
Volume—
Valuation
Market cap3.72B
P/E ratio—
EPS (TTM)-0.72
Income & risk
Dividend / yield—
Beta0.86
Avg volume17.06M
Discussion

IOVA News

Stories mentioning IOVA from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue71,43086,77167,45559,95249,32473,69458,55531,106
Cost of Goods Sold42,49835,32838,47756,66442,71523,10131,51831,368
Gross Profit28,93251,44328,9783,2886,60950,59327,037(262.00)
Operating Expenses
Research & Development62,48769,76875,17479,36375,96567,32567,03662,084
Sales General & Admin
Total Operating Expenses
Operating Income (Loss)(81,043)(73,460)(94,901)(113,774)(121,221)(86,576)(89,066)(101,914)
Interest Income1,3331,7401,2434,1043,2209,5754,0053,355
Interest Expense
Other Expense
Pretax Income(79,710)(71,720)(93,658)(109,670)(118,001)(77,001)(85,061)(98,559)
Tax Provision(665.00)184.00(2,405)1,988(1,838)1,558(1,520)(1,458)
Net Income (Loss)(79,045)(71,904)(91,253)(111,658)(116,163)(78,559)(83,541)(97,101)
Earnings Per Share (Basic)(0.19)(201.41)(0.25)(0.33)(0.36)(270.89)(0.28)(0.34)
Earnings Per Share (Diluted)(0.19)(0.33)(0.36)(270.89)(0.28)(0.34)
Weighted Average Shares Outstanding (Basic)419.00357.00364.00335.00323.00290.00303.00285.00
Weighted Average Shares Outstanding (Diluted)419.00335.00323.00290.00303.00285.00

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About IOVA

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) is a stock listed on the Nasdaq Stock Market under the ticker symbol IOVA. It last traded at $8.59 (Nov 9, 2026, 12:40 PM ET), up 6.8% on the day. That gives Iovance Biotherapeutics a market capitalisation of $3.7B.

Over the past 52 weeks IOVA has traded between $2.08 and $15.37.

Revenue for the quarter ended Mar 31, 2026 was $71.4M; a net loss of $79.0M. Revenue was up 44.8% from $49.3M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$71.4M-$79.0M-110.7%
Dec 31, 2025$86.8M-$71.9M-82.9%
Sep 30, 2025$67.5M-$91.3M-135.3%
Jun 30, 2025$60.0M-$111.7M-186.2%

From Iovance Biotherapeutics’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…